tgAAC09

BIOLOGICAL2 trials

Sponsors

International AIDS Vaccine Initiative

Conditions

HIV InfectionHIV InfectionsHuman Immunodeficiency Virus Infections

Phase 1

Safety and Immunogenicity Study of tgAAC09, a Gag-PR-RT AAV HIV Vaccine

CompletedNCT00482027

International AIDS Vaccine InitiativeHIV Infection

Start: 2003-12-31End: 2007-01-31Updated: 2013-01-16

Phase 2

Safety and Immunogenicity Study of tgAAC09, an HIV Vaccine in an Adeno-associated Virus (AAV) Capsid

CompletedNCT00888446

International AIDS Vaccine InitiativeHIV Infections, Human Immunodeficiency Virus Infections

Start: 2005-10-31End: 2007-12-31Updated: 2012-12-17